BECIZANT

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals